HROW logo

Harrow, Inc. (HROW)

Profile

Full Name

Harrow, Inc.

Ticker

NASDAQ: HROW

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

September 28, 2007

Indexes

Not included

Website

https://www.harrow.com

Employees

382

Key Details

Price

$38.79(+1.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$199.61M(+53.32% YoY)

Annual EPS

-$0.49(+34.67% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $38.79
    HROW price is $38.79

    30-Day Relative Volume

    1.18
    HROW 30-day relative volume is 1.18

    Price Performance

    Price Today change

    +1.22%
    HROW price is up +1.22% today

    Price YTD change

    +15.62%
    HROW price is up +15.62% since January 1st

    Price 1-year change

    -1.75%
    HROW price is down -1.75% year-on-year

    Price 3-year change

    +353.14%
    HROW price is up +353.14% over the past 3 years

    Price Range

    Price All-time high

    $140.00
    HROW price is currently -72.29% below its historical high of $140.00

    Price 3-year low

    $7.51
    HROW price is currently +416.50% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.44B
    HROW market capitalization is $1.44 billion

    Market cap 3-year change

    +519.4%
    HROW market capitalization is up +519.4% over the past 3 years

    Market cap All-time high

    $2.05B
    HROW market capitalization is currently -29.88% below its historical high of $2.05 billion

    Market cap sector rank

    77.94%
    HROW market capitalization is higher than 77.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.28%
    HROW shares outstanding is up +4.28% year-on-year

    Shares Outstanding 3-Year Change

    +36.69%
    HROW shares outstanding is up +36.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.47
    HROW beta is 1.47

    200-day SMA

    $32.14
    HROW price is currently +20.70% above its 200-day simple moving average

    50-day SMA

    $33.27
    HROW price is currently +16.59% above its 50-day simple moving average

    RSI

    62.85
    HROW 14-day relative strength index is 62.85

    Volume

    1.18
    HROW 30-day relative volume is 1.18

    ATR

    $2.43
    HROW average true range is $2.43

    10-day Historical Volatility

    61.50%
    HROW 10-day historical volatility is 61.50%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $199.61M
    HROW annual revenue is $199.61 million

    Revenue Analysts estimate

    $282.78M
    HROW annual revenue is currently -29.41% lower than the consensus analysts' forecast

    Revenue 1-year change

    +53.32%
    HROW annual revenue is up +53.32% year-on-year

    Revenue Sector rank

    74.05%
    HROW annual revenue is higher than 74.05% of companies in Healthcare sector

    EPS

    EPS

    -$0.49
    HROW annual earnings per share is -$0.49

    EPS Analysts estimate

    $0.79
    HROW annual earnings per share is currently -162.42% lower than the consensus analysts' forecast

    EPS 1-year change

    +34.67%
    HROW annual earnings per share is up +34.67% year-on-year

    EPS Sector rank

    63.12%
    HROW annual earnings per share is higher than 63.12% of companies in Healthcare sector

    Profit

    Gross profit

    $150.37M
    HROW annual gross profit is $150.37 million

    Gross margin

    75.33%
    HROW annual gross profit margin is 75.33%

    Operating profit

    $8.35M
    HROW annual operating income is $8.35 million

    Operating margin

    4.18%
    HROW annual operating profit margin is 4.18%

    Net income

    -$17.48M
    HROW annual net profit is -$17.48 million

    Net margin

    -8.76%
    HROW annual net profit margin is -8.76%

    Expenses

    Total expenses

    $217.09M
    HROW annual total expenses is $217.09 million

    Operating expenses

    $142.02M
    HROW annual total operating expenses is $142.02 million

    Cost of goods sold

    $49.24M
    HROW annual cost of goods sold is $49.24 million

    Selling, general & administrative expenses

    $0.00
    HROW annual SGA is $0.00

    Depreciation and amortization

    $14.54M
    HROW annual depreciation & amortization is $14.54 million

    Interest expense

    $0.00
    HROW annual interest expense is $0.00

    Income tax

    -$561.00K
    HROW annual income tax is -$561.00 thousand

    EBIT & EBITDA

    EBIT

    $8.35M
    HROW annual earnings before interest & taxes is $8.35 million

    EBITDA

    $22.89M
    HROW annual EBITDA is $22.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $388.97M
    HROW annual total assets is $388.97 million

    Non current assets

    $199.32M
    HROW annual long term assets is $199.32 million

    Current assets

    $189.65M
    HROW annual total current assets is $189.65 million

    Cash and cash equivalents

    $47.25M
    HROW annual cash & cash equivalents is $47.25 million

    Accounts receivable

    $116.37M
    HROW annual accounts receivable is $116.37 million

    Inventory

    $10.70M
    HROW annual inventory is $10.70 million

    Liabilities

    Total liabilities

    $319.67M
    HROW annual total liabilities is $319.67 million

    Long term liabilities

    $228.33M
    HROW annual total long term liabilities is $228.33 million

    Current liabilities

    $91.34M
    HROW annual total current liabilities is $91.34 million

    Accounts payable

    $38.76M
    HROW annual accounts payable is $38.76 million

    Debt

    Total debt

    $228.83M
    HROW annual total debt is $228.83 million

    Total debt 1-year change

    +18.43%
    HROW annual total debt is up +18.43% year-on-year

    Long term debt

    $228.33M
    HROW annual long term debt is $228.33 million

    Short term debt

    $497.00K
    HROW annual short term debt is $497.00 thousand

    Equity & Capital

    Shareholders equity

    $69.65M
    HROW annual stockholders equity is $69.65 million

    Book value

    $69.65M
    HROW annual book value is $69.65 million

    Retained earnings

    -$151.38M
    HROW annual retained earnings is -$151.38 million

    Working capital

    $98.31M
    HROW annual working capital is $98.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$22.20M
    HROW annual cash flow from operations is -$22.20 million

    Cash from operations 1-year change

    -678.18%
    HROW annual cash flow from operations is down -678.18% year-on-year

    Cash from investing

    -$33.16M
    HROW annual cash flow from investing activities is -$33.16 million

    Cash from investing 1-year change

    +78.26%
    HROW annual cash flow from investing activities is up +78.26% year-on-year

    Cash from financing

    $28.53M
    HROW annual cash flow from financing activities is $28.53 million

    Cash from financing 1-year change

    -77.45%
    HROW annual cash flow from financing activities is down -77.45% year-on-year

    CAPEX

    CAPEX

    $38.67M
    HROW annual capital expenditures is $38.67 million

    CAPEX 1-year change

    -74.65%
    HROW annual capital expenditures is down -74.65% year-on-year

    Free Cash Flow

    Free cash flow

    -$60.88M
    HROW annual free cash flow is -$60.88 million

    Free cash flow 1-year change

    +59.06%
    HROW annual free cash flow is up +59.06% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    75.33%
    HROW annual gross profit margin is 75.33%

    Operating margin

    4.18%
    HROW annual operating profit margin is 4.18%

    Net margin

    -8.76%
    HROW annual net profit margin is -8.76%

    ROA & ROE

    ROA

    -4.99%
    HROW annual return on assets is -4.99%

    ROE

    -25.10%
    HROW annual return on equity is -25.10%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    HROW price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    HROW price to earnings ratio is unknown

    PB Ratio

    PB ratio

    28.91
    HROW price to book ratio is 28.91

    PB ratio Sector rank

    96.43%
    HROW price to book ratio is higher than 96.43% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.30
    HROW price to sales ratio is 6.30

    PS ratio Sector rank

    64.46%
    HROW price to sales ratio is higher than 64.46% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.61B
    HROW enterprise value is $1.61 billion

    Enterprise value Sector rank

    79.3%
    HROW enterprise value is higher than 79.3% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    49.47
    HROW EV/EBITDA is 49.47

    EV/EBITDA Sector rank

    96.72%
    HROW EV/EBITDA is higher than 96.72% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.08
    HROW annual current ratio is 2.08

    Quick ratio

    1.96
    HROW annual quick ratio is 1.96

    Leverage

    Debt to equity

    3.29
    HROW annual debt to equity ratio is 3.29

    Interest coverage ratio

    -
    HROW annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    HROW piotroski f-score is 5

    Altman Z-Score

    3.04
    HROW altman z-score is 3.04

    Analyst ratings

    Recent major analysts updates

    Aug 14, 25 BTIG
    Buy
    Aug 13, 25 HC Wainwright & Co.
    Buy
    Jul 11, 25 Cantor Fitzgerald
    Overweight
    Jun 10, 25 William Blair
    Outperform
    May 12, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 B. Riley Securities
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 HC Wainwright & Co.
    Buy
    Feb 6, 25 HC Wainwright & Co.
    Buy
    Oct 4, 24 Lake Street
    Buy

    Institutional Ownership

    Screeners with HROW included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Harrow, Inc.?
    • Does Harrow, Inc. pay dividends?
    • What sector is Harrow, Inc. in?
    • What industry is Harrow, Inc. in?
    • What country is Harrow, Inc. based in?
    • When did Harrow, Inc. go public?
    • Is Harrow, Inc. in the S&P 500?
    • Is Harrow, Inc. in the NASDAQ 100?
    • Is Harrow, Inc. in the Dow Jones?
    • When was Harrow, Inc.'s last earnings report?
    • When does Harrow, Inc. report earnings?

    What is the ticker symbol for Harrow, Inc.?

    The ticker symbol for Harrow, Inc. is NASDAQ:HROW

    Does Harrow, Inc. pay dividends?

    No, Harrow, Inc. does not pay dividends

    What sector is Harrow, Inc. in?

    Harrow, Inc. is in the Healthcare sector

    What industry is Harrow, Inc. in?

    Harrow, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Harrow, Inc. based in?

    Harrow, Inc. is headquartered in United States

    When did Harrow, Inc. go public?

    Harrow, Inc.'s initial public offering (IPO) was on September 28, 2007

    Is Harrow, Inc. in the S&P 500?

    No, Harrow, Inc. is not included in the S&P 500 index

    Is Harrow, Inc. in the NASDAQ 100?

    No, Harrow, Inc. is not included in the NASDAQ 100 index

    Is Harrow, Inc. in the Dow Jones?

    No, Harrow, Inc. is not included in the Dow Jones index

    When was Harrow, Inc.'s last earnings report?

    Harrow, Inc.'s most recent earnings report was on August 11, 2025

    When does Harrow, Inc. report earnings?

    The next expected earnings date for Harrow, Inc. is November 13, 2025
    On this page